US2020113732A1PendingUtilityA1
Vacuum-assisted drug delivery device and method
Est. expiryApr 23, 2034(~7.8 yrs left)· nominal 20-yr term from priority
A61F 9/0017A61M 1/00A61M 2037/0007A61M 2210/0612A61M 35/003A61M 37/00A61M 1/0074A61M 1/0037A61M 1/0066A61M 1/802A61M 1/75A61M 1/80
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to a device and method for the vacuum-assisted delivery of drugs through an intact surface membrane of an organ.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A method for delivering a drug into an eye of a patient non-invasively for treating a disease or condition in the patient in need thereof, comprising:
placing a surface of a drug reservoir in contact with an epithelial or conjunctival surface of the eye to which the surface of the drug reservoir has been conformed such that an air-tight contact between the drug reservoir surface and the epithelial or conjunctival surface is formed and such that a fluid in the drug reservoir is placed in fluid communication with the epithelial or conjunctival surface; and creating a vacuum within the drug reservoir to effect diffusion of the fluid in the drug reservoir through the epithelial or conjunctival surface and into the subsurface of the eye.
16 . The method of claim 15 , wherein the surface of the eye is the epithelial surface.
17 . The method of claim 16 , where the fluid comprises a substance that is capable of catalyzing the cross-linking of macromolecules in the eye.
18 . The method of claim 15 , wherein the fluid comprises an anti-microbial, an anti-inflammatory, an analgesic, antiseptic, or an anti-VEGF drug.
19 . The method of claim 15 , wherein the delivery of a drug is for the treatment of uveitis, keratoconus, glaucoma, dry eye, diabetic macular edema, age-related macular degeneration, corneal infection or cytomegalovirus retinitis.
20 . The method of claim 15 , wherein the vacuum is a pressure between 1 and 100 torr.
21 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.